A detailed history of Aviance Capital Partners, LLC transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Aviance Capital Partners, LLC holds 9,752 shares of JAZZ stock, worth $1.2 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
9,752
Previous 9,749 0.03%
Holding current value
$1.2 Million
Previous $1.04 Million 4.42%
% of portfolio
0.15%
Previous 0.15%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$100.57 - $116.37 $301 - $349
3 Added 0.03%
9,752 $1.09 Million
Q2 2024

Aug 09, 2024

BUY
$103.94 - $118.98 $4,261 - $4,878
41 Added 0.42%
9,749 $1.04 Million
Q1 2024

Apr 17, 2024

SELL
$115.19 - $132.77 $91,576 - $105,552
-795 Reduced 7.57%
9,708 $1.17 Million
Q4 2023

Feb 06, 2024

SELL
$114.26 - $136.0 $9,140 - $10,880
-80 Reduced 0.76%
10,503 $1.29 Million
Q3 2023

Nov 06, 2023

BUY
$122.0 - $145.31 $35,014 - $41,703
287 Added 2.79%
10,583 $1.37 Million
Q2 2023

Aug 04, 2023

BUY
$122.5 - $147.16 $9,800 - $11,772
80 Added 0.78%
10,296 $1.28 Million
Q1 2023

May 10, 2023

BUY
$133.98 - $160.47 $13,264 - $15,886
99 Added 0.98%
10,216 $1.49 Million
Q4 2022

Feb 06, 2023

SELL
$129.72 - $159.85 $57,984 - $71,452
-447 Reduced 4.23%
10,117 $1.61 Million
Q3 2022

Nov 09, 2022

SELL
$126.59 - $161.18 $4,304 - $5,480
-34 Reduced 0.32%
10,564 $1.41 Million
Q2 2022

Aug 08, 2022

SELL
$141.59 - $168.66 $39,645 - $47,224
-280 Reduced 2.57%
10,598 $1.65 Million
Q1 2022

May 06, 2022

SELL
$129.64 - $160.7 $60,671 - $75,207
-468 Reduced 4.12%
10,878 $1.69 Million
Q3 2021

Nov 12, 2021

BUY
$128.64 - $184.79 $51,841 - $74,470
403 Added 3.68%
11,346 $1.48 Million
Q2 2021

Aug 06, 2021

SELL
$160.2 - $186.42 $3,364 - $3,914
-21 Reduced 0.19%
10,943 $1.94 Million
Q1 2021

Apr 29, 2021

SELL
$150.19 - $173.5 $77,648 - $89,699
-517 Reduced 4.5%
10,964 $1.8 Million
Q4 2020

Feb 12, 2021

SELL
$140.71 - $165.05 $5,628 - $6,602
-40 Reduced 0.35%
11,481 $1.9 Million
Q2 2020

Jul 24, 2020

SELL
$95.68 - $121.88 $15,787 - $20,110
-165 Reduced 1.41%
11,521 $1.27 Million
Q1 2020

May 05, 2020

SELL
$87.74 - $152.74 $93,530 - $162,820
-1,066 Reduced 8.36%
11,686 $1.17 Million
Q4 2019

Feb 07, 2020

SELL
$117.65 - $153.73 $181,651 - $237,359
-1,544 Reduced 10.8%
12,752 $1.9 Million
Q3 2019

Nov 07, 2019

SELL
$125.18 - $143.24 $90,630 - $103,705
-724 Reduced 4.82%
14,296 $1.83 Million
Q2 2019

Aug 12, 2019

BUY
$125.55 - $144.48 $82,235 - $94,634
655 Added 4.56%
15,020 $2.14 Million
Q1 2019

May 01, 2019

BUY
$121.81 - $142.95 $71,502 - $83,911
587 Added 4.26%
14,365 $2.05 Million
Q4 2018

Feb 11, 2019

SELL
$115.94 - $166.74 $98,549 - $141,729
-850 Reduced 5.81%
13,778 $1.71 Million
Q3 2018

Nov 09, 2018

SELL
$161.01 - $180.57 $43,472 - $48,753
-270 Reduced 1.81%
14,628 $2.46 Million
Q2 2018

Aug 10, 2018

SELL
$146.33 - $183.18 $111,942 - $140,132
-765 Reduced 4.88%
14,898 $2.57 Million
Q1 2018

May 03, 2018

SELL
$135.59 - $157.16 $58,981 - $68,364
-435 Reduced 2.7%
15,663 $2.36 Million
Q4 2017

Feb 13, 2018

SELL
$131.06 - $150.39 $55,700 - $63,915
-425 Reduced 2.57%
16,098 $2.17 Million
Q3 2017

Nov 09, 2017

BUY
$142.62 - $155.6 $2.36 Million - $2.57 Million
16,523
16,523 $2.42 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Aviance Capital Partners, LLC Portfolio

Follow Aviance Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aviance Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aviance Capital Partners, LLC with notifications on news.